Purpose
|
Deferiprone is an oral iron chelator used as a second line agent in thalassemia syndromes when iron overload from blood transfusions occurs. Thalassemias are a type of hereditary anaemia due a defect in the production of hemoglobin. As a result, erythropoiesis, the production of new red blood cells, is impaired. FDA approved on October 14, 2011.
|
Characteristics
|
Source of Compound: synthetic, L-1 Target: Chelator,UGT inhibitor Receptor: iron,UGT1-6 Status: INN, BAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
97?%
|
Formula
|
C7H9NO2
|
Solubility
|
Soluble in water
|